|
1
|
Liu W, Zhang B, Chen G, Wu W, Zhou L, Shi
Y, Zeng Q, Li Y, Sun Y, Deng X and Wang F: Targeting miR-21 with
sophocarpine inhibits tumor progression and reverses
epithelial-mesenchymal transition in head and neck cancer. Mol
Ther. 25:2129–2139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elzakra N, Cui L, Liu T, Li H, Huang J and
Hu S: Mass spectrometric analysis of SOX11-binding proteins in head
and neck cancer cells demonstrates the interaction of SOX11 and
HSP90α. J Proteome Res. 16:3961–3968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiang C, Lv Y, Wei Y, Wei J, Miao S, Mao
X, Gu X, Song K and Jia S: Effect of EphA7 silencing on
proliferation, invasion and apoptosis in human laryngeal cancer
cell lines Hep-2 and AMC-HN-8. Cell Physiol Biochem. 36:435–445.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su Z, Li G, Liu C, Ren S, Deng T, Zhang S,
Tian Y, Liu Y and Qiu Y: Autophagy inhibition impairs the
epithelial-mesenchymal transition and enhances cisplatin
sensitivity in nasopharyngeal carcinoma. Oncol Lett. 13:4147–4154.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu K, Shen B, Jiang F, Xia L, Fan T, Qin
M, Yang L, Guo J, Li Y, Zhu M, et al: TRPP2 enhances metastasis by
regulating epithelial-mesenchymal transition in laryngeal squamous
cell carcinoma. Cell Physiol Biochem. 39:2203–2215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Natarajan J, Chandrashekar C and
Radhakrishnan R: Critical biomarkers of epithelial-mesenchymal
transition in the head and neck cancers. J Cancer Res Ther.
10:512–518. 2014.PubMed/NCBI
|
|
7
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurreck J: RNA interference: From basic
research to therapeutic applications. Angew Chem Int Ed Engl.
48:1378–1398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
López-Fraga M, Martinez T and Jiménez A:
RNA interference technologies and therapeutics. From basic research
to products BioDrugs. 23:305–332. 2009.PubMed/NCBI
|
|
10
|
Ozcan G, Ozpolat B, Coleman RL, Sood AK
and Lopez-Berestein G: Preclinical and clinical development of
siRNA-based therapeutics. Adv Drug Deliv Rev. 87:108–119. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Chen W, Xie H, Wei X, Yin S, Zhou
L, Xu X and Zheng S: Biocompatible, chimeric peptide-condensed
supramolecular nanoparticles for tumor cell-specific siRNA delivery
and gene silencing. Chem Commun (Camb). 50:7806–7809. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lai RC, Yeo RW, Tan KH and Lim SK:
Exosomes for drug delivery-a novel application for the mesenchymal
stem cell. Biotechnol Adv. 31:543–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vlassov AV, Magdaleno S, Setterquist R and
Conrad R: Exosomes: Current knowledge of their composition,
biological functions, and diagnostic and therapeutic potentials.
Biochim Biophys Acta. 1820:940–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan A, Rajadas J and Seifalian AM:
Exosomes as nano-theranostic delivery platforms for gene therapy.
Adv Drug Deliv Rev. 65:357–367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Zhang L, Li Y, Chen L, Wang X, Guo
W, Zhang X, Qin G, He SH, Zimmerman A, et al:
Exosomes/microvesicles from induced pluripotent stem cells deliver
cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the
ischemic myocardium. Int J Cardiol. 192:61–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rider MA, Hurwitz SN and Meckes DG Jr:
ExtraPEG: A polyethylene glycol-based method for enrichment of
extracellular vesicles. Sci Rep. 6:239782016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao R, Zhou M, Li J, Wang X, Su K, Hu J,
Ye Y, Zhu J, Zhang G, Wang K, et al: Increased TRPP2 expression in
vascular smooth muscle cells from high-salt intake hypertensive
rats: The crucial role in vascular dysfunction. Mol Nutr Food Res.
59:365–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hurwitz SN, Nkosi D, Conlon MM, York SB,
Liu X, Tremblay DC and Meckes DG Jr: CD63 regulates epstein-barr
virus LMP1 exosomal packaging, enhancement of vesicle production,
and noncanonical NF-κB signaling. J Virol. 91(pii): e02251–16.
2017.PubMed/NCBI
|
|
20
|
Khushman M, Bhardwaj A, Patel GK, Laurini
JA, Roveda K, Tan MC, Patton MC, Singh S, Taylor W and Singh AP:
Exosomal markers (CD63 and CD9) expression pattern using
immunohistochemistry in resected malignant and nonmalignant
pancreatic specimens. Pancreas. 46:782–788. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Escola JM, Kleijmeer MJ, Stoorvogel W,
Griffith JM, Yoshie O and Geuze HJ: Selective enrichment of
tetraspan proteins on the internal vesicles of multivesicular
endosomes and on exosomes secreted by human B-lymphocytes. J Biol
Chem. 273:20121–20127. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mathivanan S, Fahner CJ, Reid GE and
Simpson RJ: ExoCarta 2012: Database of exosomal proteins, RNA and
lipids. Nucleic Acids Res. 40:(Database Issue). D1241–D1244. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsiokas L: Function and regulation of
TRPP2 at the plasma membrane. Am J Physiol Renal Physiol.
297:F1–F9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Argiris A, Harrington KJ, Tahara M,
Schulten J, Chomette P, Ferreira Castro A and Licitra L:
Evidence-based treatment options in recurrent and/or metastatic
squamous cell carcinoma of the head and neck. Front Oncol.
7:722017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferris RL, Blumenschein G Jr, Fayette J,
Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE,
Even C, et al: Nivolumab for recurrent squamous-cell carcinoma of
the head and neck. N Engl J Med. 375:1856–1867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chow LQ, Haddad R, Gupta S, Mahipal A,
Mehra R, Tahara M, Berger R, Eder JP, Burtness B, Lee SH, et al:
Antitumor activity of pembrolizumab in biomarker-unselected
patients with recurrent and/or metastatic head and neck squamous
cell carcinoma: Results from the phase Ib KEYNOTE-012 expansion
cohort. J Clin Oncol. 34:3838–3845. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu J, Guo J, Yang Y, Jiang F, Chen S, Wu
K, Shen B, Liu Y and Du J: Tumor necrosis factor alpha accelerates
Hep-2 cells proliferation by suppressing TRPP2 expression. Sci
China Life Sci. 60:1251–1259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee K, Jang B, Lee YR, Suh EY, Yoo JS, Lee
MJ, Lee JY and Lee H: The cutting-edge technologies of siRNA
delivery and their application in clinical trials. Arch Pharm Res.
41:867–874. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu F, Wang C, Gao Y, Li X, Tian F, Zhang
Y, Fu M, Li P, Wang Y and Wang F: Current transport systems and
clinical applications for small interfering RNA (siRNA) drugs. Mol
Diagn Ther. Jun 20–2018;(Epub ahead of print).
|
|
32
|
Xia H, Mao Q, Paulson HL and Davidson BL:
siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol.
20:1006–1010. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang YA, Nemunaitis J, Samuel SK, Chen P,
Shen Y and Tong AW: Antitumor activity of an oncolytic
adenovirus-delivered oncogene small interfering RNA. Cancer Res.
66:9736–9743. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
DeGroot LJ and Zhang R: Viral mediated
gene therapy for the management of metastatic thyroid carcinoma.
Curr Drug Targets Immune Endocr Metabol Disord. 4:235–244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao YD, Sun TM, Huang SY, Dou S, Lin L,
Chen JN, Ruan JB, Mao CQ, Yu FY, Zeng MS, et al: Targeted delivery
of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and
metastasis. Sci Transl Med. 4:130ra1482012. View Article : Google Scholar
|
|
36
|
Darband SG, Mirza-Aghazadeh-Attari M,
Kaviani M, Mihanfar A, Sadighparvar S, Yousefi B and Majidinia M:
Exosomes: Natural nanoparticles as bio shuttles for RNAi delivery.
J Control Release. 289:158–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
